Business Description
Bio-Techne Corp
NAICS : 325414
SIC : 2836
ISIN : US09073M1045
Share Class Description:
TECH: Ordinary SharesTotal Employee Number:
3,100Compare
Compare
Traded in other countries / regions
TECH.USATE1.GermanyT1CH34.Brazil1TECH.ItalyTECH.Mexico Index Membership
S&P 500Russell 1000Russell 3000 IPO Date
1989-05-08Description
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.72 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | 1.13 | |||||
Interest Coverage | 30.39 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 15.79 | |||||
Beneish M-Score | -2.55 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.3 | |||||
3-Year EBITDA Growth Rate | -18.6 | |||||
3-Year EPS without NRI Growth Rate | -0.9 | |||||
3-Year FCF Growth Rate | -2 | |||||
3-Year Book Growth Rate | 4.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 6.25 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.37 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 85.31 | |||||
9-Day RSI | 81.69 | |||||
14-Day RSI | 76.61 | |||||
3-1 Month Momentum % | -6.32 | |||||
6-1 Month Momentum % | -16.56 | |||||
12-1 Month Momentum % | -6.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.49 | |||||
Quick Ratio | 3.18 | |||||
Cash Ratio | 1.37 | |||||
Days Inventory | 170.38 | |||||
Days Sales Outstanding | 61.92 | |||||
Days Payable | 23.55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.45 | |||||
Dividend Payout Ratio | 0.16 | |||||
Forward Dividend Yield % | 0.45 | |||||
5-Year Yield-on-Cost % | 0.45 | |||||
3-Year Average Share Buyback Ratio | 0.4 | |||||
Shareholder Yield % | 1.72 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 64.96 | |||||
Operating Margin % | 24.31 | |||||
Net Margin % | 9.05 | |||||
EBITDA Margin % | 21.24 | |||||
FCF Margin % | 22.27 | |||||
OCF Margin % | 24.35 | |||||
ROE % | 5.48 | |||||
ROA % | 4.28 | |||||
ROIC % | 9.58 | |||||
3-Year ROIIC % | -22.24 | |||||
ROC (Joel Greenblatt) % | 24.53 | |||||
ROCE % | 6.52 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 102.64 | |||||
Forward PE Ratio | 34.62 | |||||
PE Ratio without NRI | 36.51 | |||||
Shiller PE Ratio | 58.74 | |||||
Price-to-Owner-Earnings | 86.06 | |||||
PS Ratio | 9.18 | |||||
PB Ratio | 5.32 | |||||
Price-to-Tangible-Book | 14.05 | |||||
Price-to-Free-Cash-Flow | 41.25 | |||||
Price-to-Operating-Cash-Flow | 37.71 | |||||
EV-to-EBIT | 70.88 | |||||
EV-to-Forward-EBIT | 39.84 | |||||
EV-to-EBITDA | 43.23 | |||||
EV-to-Forward-EBITDA | 28.8 | |||||
EV-to-Revenue | 9.18 | |||||
EV-to-Forward-Revenue | 8.79 | |||||
EV-to-FCF | 41.23 | |||||
Price-to-GF-Value | 0.98 | |||||
Price-to-Projected-FCF | 2.78 | |||||
Price-to-Median-PS-Value | 0.88 | |||||
Price-to-Graham-Number | 4.78 | |||||
| Price-to-Net-Current-Asset-Value | 49.88 | |||||
Earnings Yield (Greenblatt) % | 1.41 | |||||
FCF Yield % | 2.44 | |||||
Forward Rate of Return (Yacktman) % | -3.59 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TECH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bio-Techne Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,210.811 | ||
| EPS (TTM) ($) | 0.69 | ||
| Beta | 1.3625 | ||
| 3-Year Sharpe Ratio | -0.37 | ||
| 3-Year Sortino Ratio | -0.52 | ||
| Volatility % | 44.8 | ||
| 14-Day RSI | 76.61 | ||
| 14-Day ATR ($) | 2.283268 | ||
| 20-Day SMA ($) | 59.68575 | ||
| 12-1 Month Momentum % | -6.41 | ||
| 52-Week Range ($) | 43.195 - 72.16 | ||
| Shares Outstanding (Mil) | 155.81 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bio-Techne Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bio-Techne Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| First quarter earnings conference call for 2027 | 2026-11-05 08:00 | In 124 days | ||
| First quarter earnings results for 2027 | 2026-11-05 | In 123 days | ||
| General meeting for 2026 | 2026-10-30 08:00 | In 118 days | ||
| Annual report for 2026 | 2026-08-21 | In 47 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-08-06 08:00 | In 33 days | ||
| Fourth quarter earnings results for 2026 | 2026-08-06 | In 32 days | ||
| USD 0.080000 Cash Dividend | 2026-05-18 | 43.30 (-3.43%) | ||
| Guidance call for 2026 | 2026-05-12 09:20 | 47.42 (-3.99%) | ||
| Third quarter earnings conference call for 2026 | 2026-05-06 08:00 | 56.68 (+0.59%) | ||
| Third quarter earnings results for 2026 | 2026-05-06 | 56.68 (+0.59%) |
Show
Entries
Bio-Techne Corp Frequently Asked Questions
What is Bio-Techne Corp(TECH)'s stock price today?
The current price of TECH is $70.83. The 52 week high of TECH is $72.16 and 52 week low is $43.20.
When is next earnings date of Bio-Techne Corp(TECH)?
The next earnings date of Bio-Techne Corp(TECH) is 2026-08-06 Est..
Does Bio-Techne Corp(TECH) pay dividends? If so, how much?
The Dividend Yield %  of Bio-Techne Corp(TECH) is 0.45% (As of Today), Highest Dividend Payout Ratio of Bio-Techne Corp(TECH) was 0.36. The lowest was 0.16. And the median was 0.24. The  Forward Dividend Yield % of Bio-Techne Corp(TECH) is 0.45%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Articles on Bio-Techne Corp
No articles.
Headlines
See More- 1
Jun 15, 2026
Bio-Techne gains on report activist investor Ananym pushing for sale
Seeking Alpha • 10:53am
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers